Cal-K
Natural health product licensed in Canada
- Licence holder
- Somapharm (Division of Bariatrix Nutrition Inc.)
- NPN or DIN-HM
- 80042246
- Status
- Active licence
- Licence date
- 14 May 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de titanium, Eau, Microcrystalline cellulose, Parahydroxybenzoate de méthyle, (p)-hydroxybenzoate de propyle, Hypromellose, Dioxyde de silicium, EDTA, PEG-400, Stéarate de magnésium, FD&C Blue No.2 Aluminum Lake, Cire de Carnauba, Maltodextrine, Povidone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
CAL-K® is indicated for the treatment of potassium depletion in patients with hypokalaemia and metabolic acidosis; CAL-K® can be used for the prevention of potassium depletion in patients at risk of potassium depletion due to dietary therapy which results in ketosis and acidosis. CAL-K® is also indicated for the prevention of potassium depletion when the dietary intake of potassium is inadequate, provided that the patient is either acidotic or has a normal acid-base Balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80042246
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.